Blogs

Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study

By Aesthetic Multispecialty Society posted Jan 12, 2021 04:17 AM

  
.
0 comments
0 views

Permalink